Kennedy Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-45,626
| Closed | -$1.73M | – | 652 |
|
|
2022
Q4 | $1.73M | Sell |
45,626
-27,424
| -38% | -$1.04M | 0.05% | 428 |
|
|
2022
Q3 | $1.84M | Sell |
73,050
-5,631
| -7% | -$142K | 0.05% | 428 |
|
|
2022
Q2 | $2.39M | Sell |
78,681
-898
| -1% | -$27.3K | 0.07% | 398 |
|
|
2022
Q1 | $2.61M | Buy |
79,579
+55
| +0.1% | +$1.8K | 0.06% | 412 |
|
|
2021
Q4 | $2.1M | Buy |
79,524
+9,117
| +13% | +$240K | 0.04% | 449 |
|
|
2021
Q3 | $7.08M | Sell |
70,407
-883
| -1% | -$88.8K | 0.16% | 243 |
|
|
2021
Q2 | $10.1M | Sell |
71,290
-3,339
| -4% | -$473K | 0.22% | 160 |
|
|
2021
Q1 | $7.44M | Buy |
74,629
+2,625
| +4% | +$262K | 0.15% | 255 |
|
|
2020
Q4 | $8.9M | Sell |
72,004
-788
| -1% | -$97.4K | 0.2% | 169 |
|
|
2020
Q3 | $7.09M | Sell |
72,792
-656
| -0.9% | -$63.9K | 0.2% | 167 |
|
|
2020
Q2 | $11.5M | Sell |
73,448
-1,053
| -1% | -$164K | 0.33% | 66 |
|
|
2020
Q1 | $10.8M | Sell |
74,501
-1,431
| -2% | -$207K | 0.4% | 35 |
|
|
2019
Q4 | $15.5M | Sell |
75,932
-89,382
| -54% | -$18.3M | 0.38% | 39 |
|
|
2019
Q3 | $13.3M | Sell |
165,314
-25,895
| -14% | -$2.08M | 0.33% | 59 |
|
|
2019
Q2 | $18M | Sell |
191,209
-4,547
| -2% | -$429K | 0.43% | 27 |
|
|
2019
Q1 | $16.7M | Sell |
195,756
-17,759
| -8% | -$1.52M | 0.39% | 37 |
|
|
2018
Q4 | $12M | Sell |
213,515
-61,257
| -22% | -$3.44M | 0.3% | 72 |
|
|
2018
Q3 | $22.5M | Sell |
274,772
-48,029
| -15% | -$3.93M | 0.42% | 33 |
|
|
2018
Q2 | $11.3M | Buy |
322,801
+84,491
| +35% | +$2.95M | 0.21% | 134 |
|
|
2018
Q1 | $4.89M | Sell |
238,310
-11,496
| -5% | -$236K | 0.1% | 406 |
|
|
2017
Q4 | $7.08M | Buy |
249,806
+45,546
| +22% | +$1.29M | 0.13% | 283 |
|
|
2017
Q3 | $6.35M | Buy |
+204,260
| New | +$6.35M | 0.11% | 315 |
|